Viemed Healthcare Posts Record $78.1M Q2 Revenue and Raises 2026 Guidance
Viemed Healthcare reported record Q2 2026 revenue of $78.1 million, up 23.9% year over year, driven by growth in ventilator and PAP therapy patients. The company repurchased shares and ended the quarter with strong cash flow and a solid balance sheet. Viemed raised full-year 2026 revenue guidance to $314–$320 million and adjusted EBITDA guidance to $64–$68 million.